1[1]Geoffery CF. Non - alcoholic steatohepatitis: What is it, and why is it important in the Asia- Pacific region? [J] .Joumal of Gastroenterology and Hepatology,2003,18:124. 被引量：1
2[2]Bacon BR,Farahvash MJ,Janney GC,Neuschwander- Tetri BA. Non alcoholic steatohepatitis: an expanded clinical entity [ J ] .Gastroenterology, 1994,107:1103. 被引量：1
3[3]Pagano G,Pacini G,Musso G,Gambino R,Mecca F,Depetris N,et al.Non - alcoholic steatohepatitis,insulin resistance, and metabolic syndrome:Further evidence for an etiologic association[J]. Hepatology,2002, 35: 367. 被引量：1
4[4]Angulo P. Nonalcoholic fatty liver disease [ J ]. N Engl Med, 2002,16:1221. 被引量：1
5[5]Saadeh S,Younossi ZM,Remer EM,et al.The utility of radiological imaging in nonalcoholic fatty liver disease[ J ]. Gastroenterology,2002,123:745. 被引量：1
6[6]Matteoni CA,Younossi ZM,Gramlich T,et al. Nonalcoholic fatty liver disease:a spectrum of clinical and pathological severity[J] .Gastroenterology, 1999,116:1413. 被引量：1
7[7]Falck- Ytter Y,Younossi ZM,Marchesini G,McCullough AJ. Clinical features and natural history of non - alcoholic steatcsis syndromes[J]. Semin Liver Dis, 2001,21:17. 被引量：1
8[8]Younossi ZM, Diehl AM,Ong JP.Non-alcoholic fatty liver disease: an agenda for clinical research [ J ]. Hepatology, 2002, 35: 746. 被引量：1
9[9]Bugianesi E,Leone N,Vanni E,et al. Expanding the natural history of nonalcoholic steatohepatitis:from cryptogonic cirrhosis to hepatocellular carcinoma[J]. Gastroenterology, 2002,123: 134. 被引量：1
10[10]Carl M, Oneta fean - Francois Dufour. Non - alcoholic fatty liver disease: treatment options based on pathogenic considerations[J] .Swiss Med WKLY, 2002,132: 493. 被引量：1
3ANGULO P. Use of ursodeoxycholic acid in patients with liver disease[J ]. Curt Gastroenterol Rep, 2002,4 : 37. 被引量：1
4LUKIVSKAYA O, ZAVODNIK L, KNAS M, et al. Antioxidant mechanism of hepatoprotection by ursodeoxycholic acid in exoerimental alcoholic steatohepatitis[J]. Adv Med Sci , 2006,51:54. 被引量：1
